Wealthcare Advisory Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Buy
2,500
+188
+8% +$49.4K 0.01% 610
2026
Q1
$617K Buy
2,312
+23
+1% +$6.23K 0.01% 640
2025
Q4
$574K Sell
2,289
-120
-5% -$31.9K 0.01% 650
2025
Q3
$692K Sell
2,409
-13
-0.5% -$3.48K 0.01% 590
2025
Q2
$636K Sell
2,422
-13
-0.5% -$3.17K 0.01% 589
2025
Q1
$567K Sell
2,435
-108
-4% -$26.2K 0.02% 565
2024
Q4
$583K Buy
2,543
+490
+24% +$112K 0.02% 535
2024
Q3
$459K Sell
2,053
-167
-8% -$36.7K 0.01% 589
2024
Q2
$452K Buy
2,220
+276
+14% +$56.1K 0.01% 559
2024
Q1
$425K Sell
1,944
-35
-2% -$7.71K 0.01% 571
2023
Q4
$450K Buy
1,979
+2
+0.1% +$420 0.02% 504
2023
Q3
$398K Sell
1,977
-339
-15% -$71.5K 0.02% 486
2023
Q2
$480K Buy
2,316
+1
+0% +$194 0.02% 457
2023
Q1
$456K Buy
2,315
+93
+4% +$19.1K 0.02% 479
2022
Q4
$450K Buy
+2,222
New +$434K 0.02% 447
2021
Q2
Sell
-396
Closed -$87K 1276
2021
Q1
$87K Buy
+396
New +$79.5K 0.01% 710
2020
Q2
Sell
-186
Closed -$20K 910
2020
Q1
$20K Buy
+186
New +$26.8K ﹤0.01% 732

Other funds holding LH

Wealthcare Advisory Partners's LH Position: Q2 2026 in Review

Wealthcare Advisory Partners increased its Labcorp (LH) stake by 8.1% in Q2 2026, buying an estimated $49.4K and bringing the position to 2,500 shares worth $700K. The position accounts for 0.01% of the portfolio, ranked #610.

Wealthcare Advisory Partners first reported a position in LH in Q1 2020 and has held it in 17 quarters since. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Wealthcare Advisory Partners held 2,500 shares of Labcorp worth $700K as of Q2 2026.
  • Wealthcare Advisory Partners bought 188 Labcorp shares in Q2 2026, an estimated $49.4K.
  • Labcorp made up 0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #610 holding.
  • Wealthcare Advisory Partners first reported a position in Labcorp in Q1 2020 and has held it in 17 quarters since.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.